RespireRx Pharmaceuticals Inc (RSPI)

[neuroinv]

DavidAl:

<<As for the PIPE. It should have been done yesterday, last week, last month, in December.>>

Maybe, but the credit markets weren't exactly fluid and accessible November-January. I don't closely track BIO financings (Dew does, perhaps he has some data on this) but my impression is that there is a slight thawing now, in comparison to the nearly complete paralysis of December.

The question is not so much whether they should have financed in the midst of nuclear winter. In looking back at the price appreciation that occurred in anticipation of an ADHD deal and FDA go-ahead....if there was an opportunity missed, that was it. But because the possibility of nondilutive partnering money seemed high, they eschewed getting fiscal 'insurance.'

Hindsight is 20/20...I know I was not advocating doing a financing at that time.

NeuroInvestment